Unibest
← Back to patent-cliff list

CAS 141206-42-0

Codes: Lucerastat

Application context (from source-drug indications)

Fabry diseaseLucerastat

Source drugs (routes using this intermediate)

DrugTierExpiry
LucerastatTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

LucerastatOptimised routesteps: 1total yield: /
(2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol→butyraldehyde→Lucerastat

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.